Video

Key publications on oropharyngeal cancer

Radiotherapy plus Cisplatin or Cetuximab in low-risk human papillomavirus­ positive oropharyngeal cancer (De-ESCALaTE HPV): An open-label randomised controlled phase 3 trial

Chairpersons :

Sudeep Sarkar, Mehul Bhansali, Jyoti Dabholkar

Reviewer :

Vikas Talreja